When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Audentes Therapeutics (NASDAQ:BOLD) continues its progress towards the submission of its U.S. marketing application for gene therapy AT132 for X-linked myotubular myopathy (XLMTM).
More news on: Audentes Therapeutics, Healthcare stocks news,